Retatrutide is a cutting-edge triple agonist peptide that activates GLP-1, GIP, and glucagon receptors, offering a multifaceted approach to fat loss and metabolic health. In this report, we examine the lab-verified quality of the 10 mg Retatrutide vial by Peptide Hubs.
Test Details
- Test Date: April 22, 2025
- Product: Retatrutide 10 mg
- Manufacturer: Peptide Hubs
- Claimed Dosage: 10 mg per 2 mL vial
- Tested Dosage: 10.56 mg
- Purity: 99.094%
Results Summary
The independent laboratory confirmed that the tested vial contained 10.56 mg of Retatrutide — exceeding the labeled dosage — and demonstrated a high purity of 99.094%. This suggests Peptide Hubs adheres to exceptional quality control standards in its manufacturing process.
Further Reading
For an in-depth analysis of effects, stacking suggestions, and user insights, see our full Peptide Hubs Retatrutide review.
Conclusion
With lab results confirming both overdosed content and excellent purity, Peptide Hubs Retatrutide 10 mg appears to meet the expectations of researchers and performance-focused users alike. This level of transparency strengthens consumer trust in the brand’s peptide lineup.